Urgent Hospital Admissions Caused by Adverse Drug Reactions and Medication Errors-A Population-Based Study in Spain by Gina Mejía, Gina Mejía, Miriam Saiz-Rodríguez, Miriam Saiz-Rodríguez, Beatriz Gómez de Olea, Dolores Ochoa, Dolores Ochoa, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole by Dolores Ochoa, Manuel Román, Teresa Cabaleiro, Miriam Saiz-Rodríguez, Gina Mejía, Francisco Abad-Santos

Connect to this object online.

Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fast... by Manuel Román, Dolores Ochoa, Samuel Martin, Sergio Luquero, Inmaculada Gilaberte, Paula Arranz, Carlos Sánchez

Connect to this object online.

Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism by Gina Mejía-Abril, Gina Mejía-Abril, Pablo Zubiaur, Pablo Zubiaur, Marcos Navares-Gómez, Gonzalo Villapalos-García, Manuel Román, Manuel Román, Dolores Ochoa, Dolores Ochoa, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin by Gonzalo Villapalos-García, Pablo Zubiaur, Marcos Navares-Gómez, Miriam Saiz-Rodríguez, Gina Mejía-Abril, Samuel Martín-Vílchez, Manuel Román, Manuel Román, Dolores Ochoa, Dolores Ochoa, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects by Dolores Ochoa, Dolores Ochoa, Miriam Saiz-Rodríguez, Miriam Saiz-Rodríguez, Esperanza González-Rojano, Manuel Román, Manuel Román, Sergio Sánchez-Rojas, Aneta Wojnicz, Ana Ruiz-Nuño, Alfredo García-Arieta, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine by Andrea Rodríguez-Lopez, Gina Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa

Connect to this object online.

Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study by Víctor Mangas-Sanjuán, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo García-Arieta

Connect to this object online.

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics by Eva González-Iglesias, Eva González-Iglesias, Dolores Ochoa, Dolores Ochoa, Marcos Navares-Gómez, Pablo Zubiaur, Pablo Zubiaur, Marina Aldama, Tamara de la Torre, Marta de los Ríos-Rodríguez, Paula Soria-Chacartegui, Paula Soria-Chacartegui, Andrea Rodríguez-Lopez, Andrea Rodríguez-Lopez, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos, Jesús Novalbos

Connect to this object online.

Variants in <i>COMT</i>, <i>CYP3A5</i>, <i>CYP2B6,</i> and <i>ABCG2</i> Alter Quetiapine Pharmacokinetics by Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Manuel Román, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos

Connect to this object online.

Genetic Variation in <i>CYP2D6</i>, <i>UGT1A4</i>, <i>SLC6A2</i> and <i>SLCO1B1</i> Alters the Pharmacokinetics and Safety of Mirabegron by Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos

Connect to this object online.

An Investigational Study on the Role of <i>CYP2D6</i>, <i>CYP3A4</i> and <i>UGT</i>s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers by Andrea Rodríguez-Lopez, Dolores Ochoa, Paula Soria-Chacartegui, Samuel Martín-Vilchez, Marcos Navares-Gómez, Eva González-Iglesias, Sergio Luquero-Bueno, Manuel Román, Gina Mejía-Abril, Francisco Abad-Santos

Connect to this object online.

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials by Eva González-Iglesias, Dolores Ochoa, Manuel Román, Paula Soria-Chacartegui, Samuel Martín-Vilchez, Marcos Navares-Gómez, Alejandro De Miguel, Pablo Zubiaur, Andrea Rodríguez-Lopez, Francisco Abad-Santos, Francisco Abad-Santos, Jesús Novalbos

Connect to this object online.

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine by Sofía Calleja, Pablo Zubiaur, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Gina Mejia-Abril, Paula Soria-Chacartegui, Marcos Navares-Gómez, Alejandro de Miguel, Manuel Román, Samuel Martín-Vílchez, Francisco Abad-Santos, Francisco Abad-Santos

Connect to this object online.

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety by Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos

Connect to this object online.

Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain by Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria‐Chacartegui, Miriam Saiz‐Rodríguez, Lara Gutierrez, Catalina Aragonés, Diana Campodónico, Antía Gómez‐Fernández, Marcos Navares‐Gómez, Gonzalo Villapalos‐García, Gina Mejía‐Abril, Dolores Ochoa, Francisco Abad‐Santos

Connect to this object online.

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride by Diana María Campodónico, Pablo Zubiaur, Paula Soria‐Chacartegui, Ana Casajús, Gonzalo Villapalos‐García, Marcos Navares‐Gómez, Antía Gómez‐Fernández, Raúl Parra‐Garcés, Gina Mejía‐Abril, Manuel Román, Samuel Martín‐Vílchez, Dolores Ochoa, Francisco Abad‐Santos

Connect to this object online.

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers by Macarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, Gina Mejía-Abril, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Bernd Jilma, María A. Moro, Gerónimo Fernández, David Piñeiro, Marc Ribó, Víctor M. González, Ignacio Lizasoain, Francisco Abad-Santos

Connect to this object online.

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline by Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, Gina Mejía-Abril, Sergio Luquero-Bueno, Manuel Román, Dolores Ochoa, Francisco Abad-Santos

Connect to this object online.